MedEdge MEA

Samsung Health App: Can Samsung Keep You On Track with This New Feature? MedEdge MEA

Korea- Samsung Electronics has unveiled a new Medication tracking feature in its Samsung Health app, a great advancement toward consumers’ complete health management. Des...

Read More
Intravenous (IV) Bags: Are Hospitals Ready for Baxter’s Pilot? MedEdge MEA

December 2023- Baxter International Inc., known for its contributions to infusion therapies and technologies, has completed the initial phase of an inventive intravenous...

Read More
Roche’s Xolair Nears FDA Approval for Multiple Food Allergy Reduction MedEdge MEA

Basel, Switzerland- Roche is one step closer to gaining FDA approval for Xolair® (omalizumab). The agency accepts its supplemental Biologics License Application (sBLA) un...

Read More
AngioDynamics Completes PE Trial Enrollment for AlphaVac System MedEdge MEA

ALBANY, NY – AngioDynamics, a prominent medical technology company dedicated to enhancing blood flow, expanding cancer treatment options, and improving patient quality of...

Read More
Tandem Diabetes Care Launches Updated t:slim X2™ Software with Dexcom G7 Integration MedEdge MEA

San Diego, CA – Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, has announced the launch of updated t:slim X2™ insulin pump software fea...

Read More
BD Receives FDA Clearance for Fingertip Blood Collection Device MedEdge MEA

Franklin Lakes, NJ – BD (Becton, Dickinson, and Company), a prominent global medical technology company, has secured 510(k) clearances from the U.S. Federal Drug Administ...

Read More
Is Your Healthcare Hub-and-Spoke System Broken? MedEdge MEA

Understanding the Impact on Revenue, Efficiency, and Patient Satisfaction. In healthcare, the hub-and-spoke model has emerged both as a strategic solution and a challe...

Read More
Olympus Achieves Science-Based Targets Certification for Net-Zero Emissions by 2040 MedEdge MEA

Tokyo- Olympus Corporation, a global MedTech leader, has received verification from the Science Based Targets initiative (SBTi) for its ambitious net-zero greenhouse gas...

Read More
Pfizer’s Promising Oral Treatment for Obesity Shows Positive Phase 2b Results MedEdge MEA

New York- Pfizer Inc. has announced promising topline data from its Phase 2b clinical trial (NCT04707313) evaluating the oral Glucagon-like peptide-1 receptor agonist (GL...

Read More
Menu
Categories
How does it work